• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.

作者信息

Guney Ekin, Lucas Calixto-Hope G, Singh Kunwar, Pekmezci Melike, Fernandez-Pol Sebastian, Mirchia Kanish, Toland Angus, Vogel Hannes, Bannykh Serguei, Schafernak Kristian T, Alexandrescu Sanda, Mobley Bret C, Powell Suzanne, Davidson Christian J, Neltner Janna, Boué Daniel R, Hattab Eyas, Ferris Sean P, Ohgami Robert S, Rubenstein James L, Bollen Andrew W, Tihan Tarik, Perry Arie, Solomon David A, Wen Kwun Wah

机构信息

Department of Pathology, University of California, San Francisco, San Francisco, CA.

Department of Pathology, Stanford University Medical Center, Palo Alto, CA.

出版信息

Blood Adv. 2023 Jul 11;7(13):3307-3311. doi: 10.1182/bloodadvances.2022009521.

DOI:10.1182/bloodadvances.2022009521
PMID:36897259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10336256/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3486/10336256/49edbfdf4fe9/BLOODA_ADV-2022-009521-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3486/10336256/6315044fd41f/BLOODA_ADV-2022-009521-fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3486/10336256/8dcefb5bf220/BLOODA_ADV-2022-009521-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3486/10336256/49edbfdf4fe9/BLOODA_ADV-2022-009521-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3486/10336256/6315044fd41f/BLOODA_ADV-2022-009521-fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3486/10336256/8dcefb5bf220/BLOODA_ADV-2022-009521-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3486/10336256/49edbfdf4fe9/BLOODA_ADV-2022-009521-gr2.jpg

相似文献

1
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.分子谱分析确定了至少3种累及中枢神经系统的移植后淋巴细胞增生性疾病的不同类型。
Blood Adv. 2023 Jul 11;7(13):3307-3311. doi: 10.1182/bloodadvances.2022009521.
2
Posttransplant lymphoproliferative disorder after liver and kidney transplant.肝肾移植后移植后淋巴细胞增生性疾病
Exp Clin Transplant. 2014 Mar;12 Suppl 1:142-8.
3
Role of Cytomegalovirus in the Development of Posttransplant Lymphoproliferative Disorders With or Without Epstein-Barr Virus Infection.巨细胞病毒在移植后淋巴组织增生性疾病（伴或不伴 Epstein-Barr 病毒感染）发展中的作用。
Exp Clin Transplant. 2022 Aug;20(8):757-761. doi: 10.6002/ect.2021.0433. Epub 2022 Jan 14.
4
Epstein-Barr virus DNAemia in Iranian liver transplant recipients and assessment of its variation in posttransplant lymphproliferative disorder patients by quantitative polymerase chain reaction assay.伊朗肝移植受者中的爱泼斯坦-巴尔病毒血症以及通过定量聚合酶链反应测定评估移植后淋巴增殖性疾病患者中该病毒的变异情况。
Exp Clin Transplant. 2015 Apr;13 Suppl 1:306-11. doi: 10.6002/ect.mesot2014.p148.
5
A Fatal Complication of Liver Transplant: Posttransplant Lymphoproliferative Disease.肝移植的致命并发症：移植后淋巴组织增生性疾病。
Exp Clin Transplant. 2022 May;20(Suppl 3):102-104. doi: 10.6002/ect.PediatricSymp2022.O33.
6
Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.移植后浆母细胞淋巴瘤：细胞遗传学异常和缺乏 Epstein-Barr 病毒关联与前瞻性德国移植后淋巴组织增生性疾病登记处的不良预后相关。
Transplantation. 2012 Mar 15;93(5):543-50. doi: 10.1097/TP.0b013e318242162d.
7
Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients.实体器官移植受者中的爱泼斯坦-巴尔病毒与移植后淋巴细胞增生性疾病
Am J Transplant. 2009 Dec;9 Suppl 4:S87-96. doi: 10.1111/j.1600-6143.2009.02898.x.
8
Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.移植后淋巴细胞增生性疾病，单克隆性，与EB病毒相关。
Liver Transpl. 2001 May;7(5):451-2. doi: 10.1053/jlts.2001.21348.
9
Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.丙型肝炎病毒感染仅作为肝移植受者中 Epstein-Barr 病毒导致淋巴增殖性疾病（PTLD）的一个辅助因素发挥作用：国际调查。
Exp Clin Transplant. 2012 Apr;10(2):141-7. doi: 10.6002/ect.2011.0114.
10
Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation.移植后爱泼斯坦-巴尔病毒相关淋巴增殖性疾病伴原发性皮肤表现
Dermatol Online J. 2007 Oct 13;13(4):7.

引用本文的文献

1
Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.EB 病毒和免疫状态影响免疫抑制环境中非霍奇金淋巴瘤的免疫基因组学。
Haematologica. 2024 Nov 1;109(11):3615-3630. doi: 10.3324/haematol.2023.284332.
2
Primary large B-cell lymphomas of immune-privileged sites.免疫豁免部位的原发性大B细胞淋巴瘤
Blood. 2024 Dec 19;144(25):2593-2603. doi: 10.1182/blood.2023020911.
3
Post-Transplant Lymphoproliferative Disorders.移植后淋巴细胞增生性疾病

本文引用的文献

1
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.原发性中枢神经系统大B细胞淋巴瘤一种具有基因独特性的儿科亚型与良好的临床预后相关。
Blood Adv. 2022 May 24;6(10):3189-3193. doi: 10.1182/bloodadvances.2021006018.
2
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.发生于免疫抑制后的 EBV 相关原发性中枢神经系统淋巴瘤是一种独特的免疫生物学实体。
Blood. 2021 Mar 18;137(11):1468-1477. doi: 10.1182/blood.2020008520.
3
L265P mutation and loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas.
Semin Nephrol. 2024 Jan;44(1):151503. doi: 10.1016/j.semnephrol.2024.151503. Epub 2024 Mar 22.
4
How I treat posttransplant lymphoproliferative disorder.我如何治疗移植后淋巴组织增生性疾病。
Blood. 2023 Oct 26;142(17):1426-1437. doi: 10.1182/blood.2023020075.
L265P 突变和缺失是原发性中枢神经系统弥漫性大 B 细胞淋巴瘤的早期突变事件。
Blood Adv. 2019 Feb 12;3(3):375-383. doi: 10.1182/bloodadvances.2018027672.
4
Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.原发性中枢神经系统弥漫性大B细胞淋巴瘤中MYD88和CD79B突变频率以及MGMT甲基化情况
Neuropathology. 2017 Dec;37(6):509-516. doi: 10.1111/neup.12405. Epub 2017 Aug 30.
5
Genomic characterization of primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤的基因组特征。
Acta Neuropathol. 2016 Jun;131(6):865-75. doi: 10.1007/s00401-016-1536-2. Epub 2016 Jan 12.
6
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.移植后淋巴组织增生性疾病（PTLD）：危险因素、诊断和当前治疗策略。
Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5.
7
Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.原发性中枢神经系统移植后淋巴组织增生性疾病（PTLD）：现代时期 84 例国际报告。
Am J Transplant. 2013 Jun;13(6):1512-22. doi: 10.1111/ajt.12211.
8
Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?B细胞移植后淋巴细胞增殖性疾病的分子发病机制：我们目前了解多少？
Clin Dev Immunol. 2013;2013:150835. doi: 10.1155/2013/150835. Epub 2013 Apr 14.
9
A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients.一项 16 年多机构研究，探讨了年龄和 EBV 状态对儿科心脏移植受者中 PTLD 发生率的作用。
Am J Transplant. 2012 Nov;12(11):3061-8. doi: 10.1111/j.1600-6143.2012.04197.x. Epub 2012 Oct 16.
10
Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.移植后淋巴组织增生性疾病：风险、分类和治疗建议。
Curr Treat Options Oncol. 2012 Mar;13(1):122-36. doi: 10.1007/s11864-011-0177-x.